Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCA108 in Uncontrolled Hypertension
NCT07030101Phase 3Not yet recruiting
- Sponsor
- EMS
- Start
- Nov 2026
- Primary completion
- May 2029
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of TCA108 in hypertension (HTN), sponsored by EMS. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
TCA108
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT07030101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07030101.